1 year update. 23M. 1mg fin n 5% min topical every day. Is this regrowth? 5/25/2025
A 23-year-old male shares a one-year update on using 1mg finasteride and 5% minoxidil daily for hair regrowth, recently adding Revita shampoo, 2.5mg minoxidil in the morning, and Vitamin and Zinc supplements. He plans to continue this regimen and has a hair transplant scheduled for July.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity Losing ground after 14 months of fin use and 11 months of min
A 24-year-old person who is worried about their hair loss after 14 months of taking finasteride and 11 months of minoxidil. Replies to the post suggested sticking with their current regimen, that shedding from one part may not be telogen effluvium, and that shedding is normal with these drugs and they should evaluate in two to three months.
community 3month progress Oral Fin. Topical Min
A user is experiencing hair regrowth after using oral finasteride, topical minoxidil, biotin, multivitamins, vitamin D, and dutasteride. They also use ketoconazole shampoo and Revita density shampoo to manage flakes and improve hair thickness.
community What was added to your routine that sparked the most growth?
Dutasteride, RU58841, and topical minoxidil are effective for hair regrowth, with oral minoxidil showing mixed results. Some users report significant improvement with dutasteride and topical minoxidil, while others find oral minoxidil less effective.
community 2 years progress (28M). Finally posting my results
A 28-year-old shared his 2-year hair loss treatment progress using finasteride, minoxidil, dermarolling, and Revita shampoo. He saw significant improvement, especially with minoxidil and dermarolling, and stressed consistency.
community Finasteride ruined my hair, and my life (so far)
The user suspects finasteride worsened their hair loss despite no abnormal shedding and reduced hair fall initially. They are considering various options, including switching brands, trying topical finasteride, oral minoxidil, or waiting for new treatments.
Related Research
6 / 6 results
research Compounding as a Current Therapeutic Option in Dermatology
This review discusses the current role and challenges of compounding in dermatology without presenting new research results; the authors suggest its resurgence in practice despite pharmaceutical alternatives.
research Lipid nanocarriers as innovative strategies for hair regrowth
This review discusses current treatment strategies for alopecia and highlights the potential of lipid-based nanoparticles to improve drug delivery to the scalp and hair follicles, noting their ability to enhance skin penetration and drug stability while outlining associated challenges and the need for further research.
research Ingredients of Trichological Shampoos with Alleged Beneficial Effects on Hair—What Is Really Known About Their Efficacy? A Scoping Review of an Area with More Unknowns than Knowns
This study found that of the many ingredients advertised in shampoos as effective against hair loss, only caffeine, adenosine, placental proteins, and melatonin have limited clinical evidence supporting their efficacy, with most claimed active ingredients lacking any trial-based validation.
research Seaweeds as Source of Bioactive Substances and Skin Care Therapy—Cosmeceuticals, Algotheraphy, and Thalassotherapy
This article reviews the empirical use of algae in traditional remedies and highlights the need for scientific understanding of algae's bioactive compounds used in cosmetics without providing new experimental results.
research II Nanosciesce and Nanotecnology Biomedicals Symposium - Proceedings
This review discusses technological advances in liposome systems for drug delivery and reports no new clinical results; it highlights the clinical acceptance and market presence of liposomal products.
research Interventions for female pattern hair loss
This review found evidence supporting the effectiveness and safety of topical minoxidil for treating female pattern hair loss, though many included studies were at high risk of bias.